Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$18.44 - $26.41 $9,330 - $13,363
506 Added 3.57%
14,690 $298,000
Q4 2023

Feb 07, 2024

SELL
$12.64 - $30.11 $126,905 - $302,304
-10,040 Reduced 41.45%
14,184 $319,000
Q3 2023

Nov 08, 2023

BUY
$16.64 - $25.32 $63,165 - $96,114
3,796 Added 18.58%
24,224 $403,000
Q2 2023

Jul 26, 2023

BUY
$21.59 - $27.88 $139,536 - $180,188
6,463 Added 46.28%
20,428 $501,000
Q1 2023

Apr 28, 2023

BUY
$23.46 - $36.44 $16,257 - $25,252
693 Added 5.22%
13,965 $337,000
Q4 2022

Feb 01, 2023

SELL
$27.82 - $44.16 $862 - $1,368
-31 Reduced 0.23%
13,272 $392,000
Q3 2022

Oct 25, 2022

BUY
$16.33 - $51.06 $217,237 - $679,251
13,303 New
13,303 $556,000
Q2 2022

Aug 03, 2022

SELL
$17.22 - $38.47 $215,008 - $480,336
-12,486 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$32.6 - $53.05 $70,187 - $114,216
2,153 Added 20.84%
12,486 $464,000
Q4 2021

Jan 27, 2022

BUY
$36.77 - $90.91 $115,457 - $285,457
3,140 Added 43.65%
10,333 $452,000
Q3 2021

Oct 29, 2021

BUY
$41.79 - $135.3 $877 - $2,841
21 Added 0.29%
7,193 $447,000
Q2 2021

Jul 26, 2021

BUY
$32.15 - $89.72 $2,797 - $7,805
87 Added 1.23%
7,172 $613,000
Q1 2021

Apr 27, 2021

BUY
$7.09 - $87.95 $50,232 - $623,125
7,085 New
7,085 $318,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $94.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.